[ATX] YoY Annual Result on 31-Mar-2020 [#FY]

Stock
[ATX] Amplia Therapeutics Limited
Announcement Date
30-Mar-2020
Financial Year
2020
Quarter
31-Mar-2020 [#FY]
Profit Trend
YoY- -18.66%
Quarter Report
ATX's Result
ATX's Financial Summary
View:
Show?
Annual Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 1,189 1,983 1,534 34 50 580 1,798 -6.65%
PBT -7,391 -5,628 -3,815 -2,254 -1,920 -4,298 -8,874 -3.00%
Tax -1,148 -1,983 -1,534 -34 -50 -0 -1,798 -7.20%
NP -6,242 -3,644 -2,281 -2,219 -1,870 -4,298 -7,076 -2.06%
Tax Rate - - - - - - - -
Total Cost 7,432 5,628 3,815 2,254 1,920 4,878 8,874 -2.91%
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin -524.80 -183.74 -148.75 -6,484.57 -3,704.79 -740.59 -393.54 4.91%
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
EPS -0.03 -0.03 -0.02 -0.04 -0.04 -0.17 -0.30 -31.85%
EPS Diluted -0.03 -0.03 -0.02 -0.04 -0.04 -0.17 -0.30 -31.85%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.